Toll Free: 1-888-928-9744
Published: Sep, 2019 | Pages:
101 | Publisher: MAResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
The global Antibody-drug Conjugates market was valued at $XX million in 2018, and MAResearch analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028. This report provides detailed historical analysis of global market for Antibody-drug Conjugates from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Antibody-drug Conjugates market. Leading players of Antibody-drug Conjugates including: • ImmunoGen • Seattle Genetics • Roche • Takeda Market split by Type, can be divided into: • Adcetris • Kadcyla Market split by Application, can be divided into: • Breast Cancer • Lymphoma Market split by Sales Channel, can be divided into: • Direct Channel • Distribution Channel Market segment by Region/Country including: • North America (United States, Canada and Mexico) • Europe (Germany, UK, France, Italy, Russia and Spain etc.) • Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.) • South America Brazil, Argentina, Colombia and Chile etc.) • Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.) If you have any special requirement, please let us know and we can provide you the report as your requirement.
Table of Contents Chapter 1 Antibody-drug Conjugates Market Overview 1.1 Antibody-drug Conjugates Definition 1.2 Global Antibody-drug Conjugates Market Size Status and Outlook (2013-2028) 1.3 Global Antibody-drug Conjugates Market Size Comparison by Region (2013-2028) 1.4 Global Antibody-drug Conjugates Market Size Comparison by Type (2013-2028) 1.5 Global Antibody-drug Conjugates Market Size Comparison by Application (2013-2028) 1.6 Global Antibody-drug Conjugates Market Size Comparison by Sales Channel (2013-2028) 1.7 Antibody-drug Conjugates Market Dynamics 1.7.1 Market Drivers/Opportunities 1.7.2 Market Challenges/Risks 1.7.3 Market News (Mergers/Acquisitions/ Expansion) Chapter 2 Antibody-drug Conjugates Market Segment Analysis by Player 2.1 Global Antibody-drug Conjugates Sales and Market Share by Player (2016-2018) 2.2 Global Antibody-drug Conjugates Revenue and Market Share by Player (2016-2018) 2.3 Global Antibody-drug Conjugates Average Price by Player (2016-2018) 2.4 Players Competition Situation & Trends 2.5 Conclusion of Segment by Player Chapter 3 Antibody-drug Conjugates Market Segment Analysis by Type 3.1 Global Antibody-drug Conjugates Market by Type 3.1.1 Adcetris 3.1.2 Kadcyla 3.2 Global Antibody-drug Conjugates Sales and Market Share by Type (2013-2018) 3.3 Global Antibody-drug Conjugates Revenue and Market Share by Type (2013-2018) 3.4 Global Antibody-drug Conjugates Average Price by Type (2013-2018) 3.5 Leading Players of Antibody-drug Conjugates by Type in 2018 3.6 Conclusion of Segment by Type Chapter 4 Antibody-drug Conjugates Market Segment Analysis by Application 4.1 Global Antibody-drug Conjugates Market by Application 4.1.1 Breast Cancer 4.1.2 Lymphoma 4.2 Global Antibody-drug Conjugates Sales and Market Share by Application (2013-2018) 4.3 Leading Consumers of Antibody-drug Conjugates by Application in 2018 4.4 Conclusion of Segment by Application Chapter 5 Antibody-drug Conjugates Market Segment Analysis by Sales Channel 5.1 Global Antibody-drug Conjugates Market by Sales Channel 5.1.1 Direct Channel 5.1.2 Distribution Channel 5.2 Global Antibody-drug Conjugates Sales and Market Share by Sales Channel (2013-2018) 5.3 Leading Distributors/Dealers of Antibody-drug Conjugates by Sales Channel in 2018 5.4 Conclusion of Segment by Sales Channel Chapter 6 Antibody-drug Conjugates Market Segment Analysis by Region 6.1 Global Antibody-drug Conjugates Market Size and CAGR by Region (2013-2028) 6.2 Global Antibody-drug Conjugates Sales and Market Share by Region (2013-2018) 6.3 Global Antibody-drug Conjugates Revenue and Market Share by Region (2013-2018) 6.4 North America 6.4.1 North America Market by Country 6.4.2 North America Antibody-drug Conjugates Market Share by Type 6.4.3 North America Antibody-drug Conjugates Market Share by Application 6.4.4 United States 6.4.5 Canada 6.4.6 Mexico 6.5 Europe 6.5.1 Europe Market by Country 6.5.2 Europe Antibody-drug Conjugates Market Share by Type 6.5.3 Europe Antibody-drug Conjugates Market Share by Application 6.5.4 Germany 6.5.5 UK 6.5.6 France 6.5.7 Italy 6.5.8 Russia 6.5.9 Spain 6.6 Asia-Pacific 6.6.1 Asia-Pacific Market by Country 6.6.2 Asia-Pacific Antibody-drug Conjugates Market Share by Type 6.6.3 Asia-Pacific Antibody-drug Conjugates Market Share by Application 6.6.4 China 6.6.5 Japan 6.6.6 Korea 6.6.7 India 6.6.8 Southeast Asia 6.6.9 Australia 6.7 South America 6.7.1 South America Market by Country 6.7.2 South America Antibody-drug Conjugates Market Share by Type 6.7.3 South America Antibody-drug Conjugates Market Share by Application 6.7.4 Brazil 6.7.5 Argentina 6.7.6 Colombia 6.7.7 Chile 6.8 Middle East & Africa 6.8.1 Middle East & Africa Market by Country 6.8.2 Middle East & Africa Antibody-drug Conjugates Market Share by Type 6.8.3 Middle East & Africa Antibody-drug Conjugates Market Share by Application 6.8.4 Egypt 6.8.5 Saudi Arabia 6.8.6 South Africa 6.8.7 Nigeria 6.9 Conclusion of Segment by Region Chapter 7 Profile of Leading Antibody-drug Conjugates Players 7.1 ImmunoGen 7.1.1 Company Snapshot 7.1.2 Product/Business Offered 7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share) 7.1.4 Strategy and SWOT Analysis 7.2 Seattle Genetics 7.3 Roche 7.4 Takeda Chapter 8 Upstream and Downstream Analysis of Antibody-drug Conjugates 8.1 Industrial Chain of Antibody-drug Conjugates 8.2 Upstream of Antibody-drug Conjugates 8.2.1 Raw Materials 8.2.2 Labor Cost 8.2.3 Manufacturing Expenses 8.2.4 Manufacturing Cost Structure 8.2.5 Manufacturing Process 8.3 Downstream of Antibody-drug Conjugates 8.3.1 Leading Distributors/Dealers of Antibody-drug Conjugates 8.3.2 Leading Consumers of Antibody-drug Conjugates Chapter 9 Development Trend of Antibody-drug Conjugates (2019-2028) 9.1 Global Antibody-drug Conjugates Market Size (Sales and Revenue) Forecast (2019-2028) 9.2 Global Antibody-drug Conjugates Market Size and CAGR Forecast by Region (2019-2028) 9.3 Global Antibody-drug Conjugates Market Size and CAGR Forecast by Type (2019-2028) 9.4 Global Antibody-drug Conjugates Market Size and CAGR Forecast by Application (2019-2028) 9.5 Global Antibody-drug Conjugates Market Size Forecast by Sales Channel (2019-2028) Chapter 10 Appendix 10.1 Research Methodology 10.2 Data Sources 10.3 Disclaimer 10.4 Analysts Certification
List of Tables and Figures Figure Antibody-drug Conjugates Example Figure Global Antibody-drug Conjugates Revenue (Million $) Status and Outlook (2013-2028) Figure Global Antibody-drug Conjugates Revenue (Million $) Comparison by Region (2013-2028) Figure Global Antibody-drug Conjugates Sales Comparison by Type (2013-2028) Figure Global Antibody-drug Conjugates Sales Comparison by Application (2013-2028) Figure Global Antibody-drug Conjugates Sales Comparison by Sales Channel (2013-2028) Table Global Antibody-drug Conjugates Sales by Player (2016-2018) Table Global Antibody-drug Conjugates Sales Market Share by Player (2016-2018) Figure Global Antibody-drug Conjugates Sales Market Share by Player in 2018 Table Global Antibody-drug Conjugates Revenue (Million $) by Player (2016-2018) Table Global Antibody-drug Conjugates Revenue Market Share by Player (2016-2018) Figure Global Antibody-drug Conjugates Revenue Market Share by Player in 2018 Table Global Antibody-drug Conjugates Average Price by Player (2016-2018) Figure Global Antibody-drug Conjugates Average Price by Player in 2018 Figure Global Antibody-drug Conjugates Players Competition Situation - Top 5 Players' Revenue Market Share in 2016 Figure Global Antibody-drug Conjugates Players Competition Trends - Top 5 Players' Revenue Market Share in 2018 Figure Example of Adcetris Figure Global Adcetris Sales and Growth Rate (2013-2018) Figure Example of Kadcyla Figure Global Kadcyla Sales and Growth Rate (2013-2018) Table Global Antibody-drug Conjugates Sales by Type (2013-2018) Table Global Antibody-drug Conjugates Sales Market Share by Type (2013-2018) Figure Global Antibody-drug Conjugates Sales Market Share by Type in 2018 Table Global Antibody-drug Conjugates Revenue (Million $) by Type (2013-2018) Table Global Antibody-drug Conjugates Revenue Market Share by Type (2013-2018) Figure Global Antibody-drug Conjugates Revenue Market Share by Type in 2018 Table Global Antibody-drug Conjugates Average Price by Type (2013-2018) Figure Global Antibody-drug Conjugates Average Price by Type in 2018 Table Leading Players of Antibody-drug Conjugates by Type in 2018 Figure Example of Breast Cancer Figure Global Antibody-drug Conjugates for Breast Cancer Sales and Growth Rate (2013-2018) Figure Example of Lymphoma Figure Global Antibody-drug Conjugates for Lymphoma Sales and Growth Rate (2013-2018) Table Global Antibody-drug Conjugates Sales by Application (2013-2018) Table Global Antibody-drug Conjugates Sales Market Share by Application (2013-2018) Figure Global Antibody-drug Conjugates Sales Market Share by Application in 2018 Table Leading Consumers of Antibody-drug Conjugates by Application in 2018 Figure Example of Direct Channel Figure Global Antibody-drug Conjugates for Direct Channel Sales and Growth Rate (2013-2018) Figure Example of Distribution Channel Figure Global Antibody-drug Conjugates for Distribution Channel Sales and Growth Rate (2013-2018) Table Global Antibody-drug Conjugates Sales by Sales Channel (2013-2018) Table Global Antibody-drug Conjugates Sales Market Share by Sales Channel (2013-2018) Figure Global Antibody-drug Conjugates Sales Market Share by Sales Channel in 2018 Table Leading Distributors/Dealers of Antibody-drug Conjugates by Sales Channel in 2018 Table Global Antibody-drug Conjugates Market Size and CAGR by Region (2013-2028) Table Global Antibody-drug Conjugates Sales by Region (2013-2018) Table Global Antibody-drug Conjugates Sales Market Share by Region (2013-2018) Figure Global Antibody-drug Conjugates Sales Market Share by Region in 2018 Table Global Antibody-drug Conjugates Revenue (Million $) by Region (2013-2018) Table Global Antibody-drug Conjugates Revenue Market Share by Region (2013-2018) Figure Global Antibody-drug Conjugates Revenue Market Share by Region in 2018 Table North America Antibody-drug Conjugates Sales by Country (2013-2018) Figure North America Antibody-drug Conjugates Sales Market Share by Country (2013-2018) Table North America Antibody-drug Conjugates Revenue by Country (2013-2018) Figure North America Antibody-drug Conjugates Revenue Market Share by Country (2013-2018) Figure North America Antibody-drug Conjugates Sales Market Share by Type in 2018 Figure North America Antibody-drug Conjugates Sales Market Share by Application in 2018 Figure United States Antibody-drug Conjugates Sales and Growth Rate (2013-2018) Figure United States Antibody-drug Conjugates Revenue (Million $) and Growth Rate (2013-2018) Figure Canada Antibody-drug Conjugates Sales and Growth Rate (2013-2018) Figure Canada Antibody-drug Conjugates Revenue (Million $) and Growth Rate (2013-2018) Figure Mexico Antibody-drug Conjugates Sales and Growth Rate (2013-2018) Figure Mexico Antibody-drug Conjugates Revenue (Million $) and Growth Rate (2013-2018) Table Europe Antibody-drug Conjugates Sales by Country (2013-2018) Figure Europe Antibody-drug Conjugates Sales Market Share by Country (2013-2018) Table Europe Antibody-drug Conjugates Revenue by Country (2013-2018) Figure Europe Antibody-drug Conjugates Revenue Market Share by Country (2013-2018) Figure Europe Antibody-drug Conjugates Sales Market Share by Type in 2018 Figure Europe Antibody-drug Conjugates Sales Market Share by Application in 2018 Figure Germany Antibody-drug Conjugates Sales and Growth Rate (2013-2018) Figure Germany Antibody-drug Conjugates Revenue (Million $) and Growth Rate (2013-2018) Figure UK Antibody-drug Conjugates Sales and Growth Rate (2013-2018) Figure UK Antibody-drug Conjugates Revenue (Million $) and Growth Rate (2013-2018) Figure France Antibody-drug Conjugates Sales and Growth Rate (2013-2018) Figure France Antibody-drug Conjugates Revenue (Million $) and Growth Rate (2013-2018) Figure Italy Antibody-drug Conjugates Sales and Growth Rate (2013-2018) Figure Italy Antibody-drug Conjugates Revenue (Million $) and Growth Rate (2013-2018) Figure Russia Antibody-drug Conjugates Sales and Growth Rate (2013-2018) Figure Russia Antibody-drug Conjugates Revenue (Million $) and Growth Rate (2013-2018) Figure Spain Antibody-drug Conjugates Sales and Growth Rate (2013-2018) Figure Spain Antibody-drug Conjugates Revenue (Million $) and Growth Rate (2013-2018) Table Asia-Pacific Antibody-drug Conjugates Sales by Country (2013-2018) Figure Asia-Pacific Antibody-drug Conjugates Sales Market Share by Country (2013-2018) Table Asia-Pacific Antibody-drug Conjugates Revenue by Country (2013-2018) Figure Asia-Pacific Antibody-drug Conjugates Revenue Market Share by Country (2013-2018) Figure Asia-Pacific Antibody-drug Conjugates Sales Market Share by Type in 2018 Figure Asia-Pacific Antibody-drug Conjugates Sales Market Share by Application in 2018 Figure China Antibody-drug Conjugates Sales and Growth Rate (2013-2018) Figure China Antibody-drug Conjugates Revenue (Million $) and Growth Rate (2013-2018) Figure Japan Antibody-drug Conjugates Sales and Growth Rate (2013-2018) Figure Japan Antibody-drug Conjugates Revenue (Million $) and Growth Rate (2013-2018) Figure Korea Antibody-drug Conjugates Sales and Growth Rate (2013-2018) Figure Korea Antibody-drug Conjugates Revenue (Million $) and Growth Rate (2013-2018) Figure India Antibody-drug Conjugates Sales and Growth Rate (2013-2018) Figure India Antibody-drug Conjugates Revenue (Million $) and Growth Rate (2013-2018) Figure Southeast Asia Antibody-drug Conjugates Sales and Growth Rate (2013-2018) Figure Southeast Asia Antibody-drug Conjugates Revenue (Million $) and Growth Rate (2013-2018) Figure Australia Antibody-drug Conjugates Sales and Growth Rate (2013-2018) Figure Australia Antibody-drug Conjugates Revenue (Million $) and Growth Rate (2013-2018) Table South America Antibody-drug Conjugates Sales by Country (2013-2018) Figure South America Antibody-drug Conjugates Sales Market Share by Country (2013-2018) Table South America Antibody-drug Conjugates Revenue by Country (2013-2018) Figure South America Antibody-drug Conjugates Revenue Market Share by Country (2013-2018) Figure South America Antibody-drug Conjugates Sales Market Share by Type in 2018 Figure South America Antibody-drug Conjugates Sales Market Share by Application in 2018 Figure Brazil Antibody-drug Conjugates Sales and Growth Rate (2013-2018) Figure Brazil Antibody-drug Conjugates Revenue (Million $) and Growth Rate (2013-2018) Figure Argentina Antibody-drug Conjugates Sales and Growth Rate (2013-2018) Figure Argentina Antibody-drug Conjugates Revenue (Million $) and Growth Rate (2013-2018) Figure Colombia Antibody-drug Conjugates Sales and Growth Rate (2013-2018) Figure Colombia Antibody-drug Conjugates Revenue (Million $) and Growth Rate (2013-2018) Figure Chile Antibody-drug Conjugates Sales and Growth Rate (2013-2018) Figure Chile Antibody-drug Conjugates Revenue (Million $) and Growth Rate (2013-2018) Table Middle East & Africa Antibody-drug Conjugates Sales by Country (2013-2018) Figure Middle East & Africa Antibody-drug Conjugates Sales Market Share by Country (2013-2018) Table Middle East & Africa Antibody-drug Conjugates Revenue by Country (2013-2018) Figure Middle East & Africa Antibody-drug Conjugates Revenue Market Share by Country (2013-2018) Figure Middle East & Africa Antibody-drug Conjugates Sales Market Share by Type in 2018 Figure Middle East & Africa Antibody-drug Conjugates Sales Market Share by Application in 2018 Figure Egypt Antibody-drug Conjugates Sales and Growth Rate (2013-2018) Figure Egypt Antibody-drug Conjugates Revenue (Million $) and Growth Rate (2013-2018) Figure Saudi Arabia Antibody-drug Conjugates Sales and Growth Rate (2013-2018) Figure Saudi Arabia Antibody-drug Conjugates Revenue (Million $) and Growth Rate (2013-2018) Figure South Africa Antibody-drug Conjugates Sales and Growth Rate (2013-2018) Figure South Africa Antibody-drug Conjugates Revenue (Million $) and Growth Rate (2013-2018) Figure Nigeria Antibody-drug Conjugates Sales and Growth Rate (2013-2018) Figure Nigeria Antibody-drug Conjugates Revenue (Million $) and Growth Rate (2013-2018) Table Company Snapshot of ImmunoGen Table Antibody-drug Conjugates Introduction of ImmunoGen Table Antibody-drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share of ImmunoGen (2016-2018) Table Industrial Chain of Antibody-drug Conjugates Table Manufacturing Cost Structure of Antibody-drug Conjugates Table General Manufacturing Process of Antibody-drug Conjugates Table Leading Distributors/Dealers of Antibody-drug Conjugates Table Leading Consumers of Antibody-drug Conjugates Figure Global Antibody-drug Conjugates Sales and Growth Rate Forecast (2019-2028) Figure Global Antibody-drug Conjugates Revenue and Growth Rate Forecast (2019-2028) Table Global Antibody-drug Conjugates Market Size and CAGR Forecast by Region (2019-2028) Table Global Antibody-drug Conjugates Market Size and CAGR Forecast by Type (2019-2028) Table Global Antibody-drug Conjugates Market Size and CAGR Forecast by Application (2019-2028) Table Global Antibody-drug Conjugates Market Size and CAGR Forecast by Sales Channel (2019-2028)
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.